Rockwell Medical (RMTI) Reports Q1 Loss of $0.84/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
May 16, 2022 4:02 PM EDT- First quarter net sales of $16.1 million, up 4.2% year-over-year -Â
- Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Trial -
- Amended and expanded supply agreement with DaVita, including $7.5M investment, strengthens Rockwell's financial position, laying groundwork for profitable concentrates business -
- Completion of patient enrollment ahead of schedule in pivotal Phase 3 trial of Triferic® in China -
- Conference call and webcast scheduled for today at 4:15 p.m. ET... More
